Contineum Therapeutics, Inc. Class A (CTNM) Ownership - Who Owns Contineum Therapeutics, Inc. Class A?

223 Followers

Contineum Therapeutics, Inc. Class A (CTNM) Ownership Overview

0.50% Insiders

8.81% Mutual Funds

49.93% Other Institutional Investors

5.32% ETFs

35.44% Public Companies and

Individual Investors

The ownership structure of Contineum Therapeutics, Inc. Class A (CTNM) stock is a mix of institutional, retail, and individual investors. Approximately 64.06% of the company’s stock is owned by Institutional Investors, 0.50% is owned by Insiders, and 35.44% is owned by Public Companies and Individual Investors.

The ownership structure of Contineum Therapeutics, Inc. Class A (CTNM) stock is a mix of institutional, retail, and individual investors. Approximately 58.73% of the company’s stock is owned by Institutional Investors, 0.50% is owned by Insiders, and 5.32% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Jun 30, 2024	Perceptive Advisors Llc	xxxxxxxxxxxxx	$16398032
Jun 30, 2024	Ra Capital Management	xxxxxxxxxxxxx	$16925917

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
Felix Baker	1,420,838	Institution	4.34%	17,618,391
Peter Kolchinsky	1,296,012	Institution	3.96%	16,070,549
Joseph Edelman	1,255,592	Institution	3.84%	15,569,341
	1,185,682	Institution	3.62%	14,702,457
	1,183,543	Institution	3.62%	14,675,933
	676,121	Institution	2.07%	8,383,900
Brad Bolzon	542,628	Institution	1.66%	6,728,587
	450,000	Institution	1.38%	5,580,000
	311,041	Institution	0.95%	3,856,908
	280,000	Institution	0.86%	3,472,000

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,183,543	Institution	3.62%	14,675,933
676,121	Institution	2.07%	8,383,900
450,000	Institution	1.38%	5,580,000
280,000	Institution	0.86%	3,472,000
175,935	Institution	0.54%	2,181,594
49,280	Institution	0.15%	611,072
16,648	Institution	0.05%	206,435
15,969	Institution	0.05%	198,016
13,802	Institution	0.04%	171,145
11,300	Institution	0.03%	140,120

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	910,659	Institution	2.78%	12,284,790
Vanguard Extended Market ETF	275,023	Institution	0.84%	3,710,060
iShares Biotechnology ETF	203,873	Institution	0.62%	2,528,025
Schwab U.S. Small-Cap ETF	115,518	Institution	0.35%	1,469,389
iShares Micro-Cap ETF	62,735	Institution	0.19%	777,914
Dimensional U.S. Small Cap ETF	54,517	Institution	0.17%	693,456
Avantis U.S Small Cap Equity ETF	42,404	Institution	0.13%	539,379
iShares NASDAQ US Biotechnology UCITS ETF	22,378	Institution	0.07%	284,648
Schwab U.S. Broad Market ETF	10,500	Institution	0.03%	133,560
U.S. Micro Cap Portfolio ETF	8,419	Institution	0.03%	109,952

FAQ

Who Owns Contineum Therapeutics, Inc. Class A (CTNM)?

According to the latest TipRanks data, approximately 49.93% of the company's stock is held by institutional investors, 0.50% is held by insiders, and 35.44% is held by retail investors.

What percentage of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by institutional investors?

According to the latest TipRanks data, approximately 49.93% of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by institutional investors.

What percentage of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by retail investors?

According to the latest TipRanks data, approximately 35.44% of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by retail investors.

Who owns the most shares of Contineum Therapeutics, Inc. Class A (CTNM)?

Felix Baker owns the most shares of Contineum Therapeutics, Inc. Class A (CTNM).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.